Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

for
Breast Cancer, Early-stage Breast Cancer
Location: Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female

Age: 18+

Code: NCT06536881

Recruiting

Pre-operative Hypofractionated Proton Therapy

for
Soft Tissue Sarcoma
Location: Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05917301

Recruiting

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Washington D.C. DC, Alexandria VA, Fairfax VA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06500481

Phase 3, Recruiting

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

for
Breast Cancer, Insomnia, Weight Gain
Location: Washington D.C. DC, Baltimore MD, Lutherville MD
Sponsor: Johns Hopkins University

Sex: Female

Age: 18+

Code: NCT05780814

Recruiting

Proton Radiation Therapy Registry

for
Cancer, Therapy-Related
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT04376229

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06810544

Phase 1, Phase 2, Recruiting

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Johns Hopkins University

Sex: Male

Age: 18+

Code: NCT05792722

Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Washington D.C. DC, Baltimore MD, Elkton MD, Newark DE,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase 1, Phase 2, Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07419295

Phase 3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

for
Advanced Renal Cell Carcinoma (RCC)
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07293351

Phase 1, Phase 2, Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: Washington D.C. DC, Baltimore MD, Charlottesville VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase 2, Phase 3, Recruiting

Pediatric Radiation Therapy Registry

for
Sarcoma, Pediatric Brain Tumors
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 0 - 26

Code: NCT07129317

Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Frederick MD,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase 3, Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Washington D.C. DC, Harrisburg PA, Sewell NJ,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase 3, Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD, York PA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase 3, Recruiting

Blue Light Cystoscopy With Cysview® Registry

for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Photocure

Sex: All

Age: 18+

Code: NCT02660645

Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Washington D.C. DC, Baltimore MD, Frederick MD,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT06525571

Phase 3, Recruiting

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

for
Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer,
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05312671

Phase 2, Recruiting